Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CRISPR-Cas Systems | 7 | 2024 | 317 | 1.680 |
Why?
|
| Gene Editing | 5 | 2024 | 238 | 1.560 |
Why?
|
| Mice, Knockout | 9 | 2025 | 3819 | 0.740 |
Why?
|
| Testicular Neoplasms | 3 | 2021 | 112 | 0.710 |
Why?
|
| Embryonic Germ Cells | 3 | 2021 | 7 | 0.650 |
Why?
|
| Teratoma | 3 | 2021 | 120 | 0.590 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.540 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 177 | 0.500 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 15 | 0.480 |
Why?
|
| Mice | 27 | 2026 | 18301 | 0.470 |
Why?
|
| Cyclin D1 | 1 | 2016 | 106 | 0.460 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2012 | 235 | 0.410 |
Why?
|
| Disease Models, Animal | 6 | 2026 | 4697 | 0.380 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 330 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 587 | 0.370 |
Why?
|
| Animals | 27 | 2026 | 33912 | 0.360 |
Why?
|
| Genes, Essential | 2 | 2024 | 39 | 0.250 |
Why?
|
| Axin Protein | 1 | 2026 | 32 | 0.240 |
Why?
|
| Exons | 4 | 2023 | 759 | 0.230 |
Why?
|
| Oocytes | 2 | 2024 | 283 | 0.220 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 14 | 0.220 |
Why?
|
| Alleles | 5 | 2024 | 1673 | 0.220 |
Why?
|
| RANK Ligand | 1 | 2025 | 51 | 0.210 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 15 | 0.210 |
Why?
|
| Viral Tropism | 1 | 2025 | 55 | 0.210 |
Why?
|
| Zygote | 1 | 2024 | 28 | 0.210 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1928 | 0.200 |
Why?
|
| Mice, Transgenic | 6 | 2024 | 2326 | 0.200 |
Why?
|
| Osteoblasts | 1 | 2025 | 175 | 0.200 |
Why?
|
| Dependovirus | 1 | 2025 | 160 | 0.200 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 291 | 0.190 |
Why?
|
| DNA Helicases | 1 | 2025 | 239 | 0.190 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 167 | 0.190 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 115 | 0.190 |
Why?
|
| Integrases | 1 | 2023 | 157 | 0.180 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 133 | 0.180 |
Why?
|
| Embryonal Carcinoma Stem Cells | 2 | 2021 | 6 | 0.180 |
Why?
|
| Germ Cells | 1 | 2023 | 201 | 0.180 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 819 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 187 | 0.180 |
Why?
|
| Bone and Bones | 2 | 2021 | 308 | 0.170 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 12 | 0.170 |
Why?
|
| Coatomer Protein | 1 | 2021 | 28 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 324 | 0.170 |
Why?
|
| Sex Differentiation | 1 | 2021 | 18 | 0.170 |
Why?
|
| Genetic Vectors | 1 | 2025 | 892 | 0.170 |
Why?
|
| Endometriosis | 1 | 2024 | 176 | 0.160 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 92 | 0.160 |
Why?
|
| Osteoporosis | 1 | 2021 | 133 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 680 | 0.150 |
Why?
|
| Mice, 129 Strain | 2 | 2018 | 96 | 0.150 |
Why?
|
| Population Health | 1 | 2020 | 35 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 12 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1075 | 0.140 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 59 | 0.140 |
Why?
|
| Disease | 1 | 2020 | 121 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 1211 | 0.140 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 67 | 0.140 |
Why?
|
| Female | 12 | 2026 | 70963 | 0.130 |
Why?
|
| Male | 11 | 2026 | 64957 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 440 | 0.120 |
Why?
|
| Mutation | 3 | 2026 | 6099 | 0.120 |
Why?
|
| Leydig Cells | 1 | 2016 | 21 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 781 | 0.120 |
Why?
|
| Retroviridae Infections | 2 | 2012 | 10 | 0.120 |
Why?
|
| Sertoli Cells | 1 | 2016 | 73 | 0.120 |
Why?
|
| Meiosis | 1 | 2016 | 111 | 0.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2012 | 100 | 0.110 |
Why?
|
| DNA Damage | 1 | 2019 | 511 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 263 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2465 | 0.110 |
Why?
|
| Intestinal Polyposis | 1 | 2015 | 17 | 0.110 |
Why?
|
| Mitosis | 1 | 2016 | 191 | 0.110 |
Why?
|
| Gene Expression | 2 | 2017 | 1481 | 0.110 |
Why?
|
| Tumor Virus Infections | 2 | 2012 | 131 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 516 | 0.110 |
Why?
|
| Software | 1 | 2020 | 733 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 371 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 218 | 0.100 |
Why?
|
| Interleukins | 1 | 2015 | 122 | 0.100 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1089 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2025 | 950 | 0.100 |
Why?
|
| Neurons | 1 | 2023 | 1979 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1282 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2023 | 2406 | 0.100 |
Why?
|
| Phenotype | 4 | 2026 | 4497 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 262 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 1559 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4738 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2023 | 324 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 621 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3748 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 133 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 418 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2026 | 0.060 |
Why?
|
| Humans | 13 | 2026 | 131163 | 0.060 |
Why?
|
| Tankyrases | 1 | 2026 | 16 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 849 | 0.060 |
Why?
|
| Ectodermal Dysplasia | 1 | 2026 | 62 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 533 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 9 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 10 | 0.060 |
Why?
|
| Wnt Signaling Pathway | 1 | 2026 | 223 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3436 | 0.050 |
Why?
|
| Serogroup | 1 | 2025 | 62 | 0.050 |
Why?
|
| Bone Development | 1 | 2025 | 58 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2025 | 69 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2025 | 358 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 276 | 0.050 |
Why?
|
| Heterozygote | 1 | 2026 | 737 | 0.050 |
Why?
|
| Transgenes | 1 | 2025 | 316 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 118 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2024 | 161 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 66 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 526 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 765 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 189 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 170 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2023 | 88 | 0.050 |
Why?
|
| Drosophila | 1 | 2026 | 739 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2023 | 181 | 0.040 |
Why?
|
| Progesterone | 1 | 2024 | 439 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2023 | 206 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 157 | 0.040 |
Why?
|
| Estrogens | 1 | 2024 | 434 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 72 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 110 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 92 | 0.040 |
Why?
|
| Spermatogonia | 1 | 2021 | 27 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 141 | 0.040 |
Why?
|
| Endometrium | 1 | 2024 | 292 | 0.040 |
Why?
|
| Genome | 1 | 2023 | 451 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2023 | 401 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3175 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 677 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 588 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 208 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 101 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2025 | 713 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 266 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 664 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 619 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 650 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 72 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 122 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 11 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 1006 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 566 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 274 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1590 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1535 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2017 | 83 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 4686 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 435 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 64 | 0.030 |
Why?
|
| Mast Cells | 1 | 2015 | 68 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1591 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1133 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2015 | 188 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 15110 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 227 | 0.030 |
Why?
|
| Colonic Polyps | 1 | 2015 | 82 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2885 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1652 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3061 | 0.020 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2012 | 27 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 235 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 992 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1621 | 0.020 |
Why?
|
| Wound Healing | 1 | 2015 | 490 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2595 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2015 | 905 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1205 | 0.020 |
Why?
|
| Child | 2 | 2021 | 26341 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2833 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 597 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1827 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1103 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2550 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 10103 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20987 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31282 | 0.010 |
Why?
|